USP22 and hepatocellular carcinoma: To investigate the mechanism by which USP22 silencing inhibits HCC cells, flow cytometry was used to determine the rate of cell apoptosis, and Western blot analysis was performed to analyze apoptosis-related changes in protein expression levels.